ARCHIVES

In Brief: Hatch Restores NCI Budget Bypass Authority In His Bill Renewing National Cancer Act

This article is from The Cancer Letter archive.

Vol. 08 No. 17 | April 23, 1982

Download PDF Visit The Full Archive

Related Articles

ASCO: NCI Director Should Be A Clinician; NBCC Endorses Mary-Claire King

March 10, 1995

NCI CTEP Approved Trials For the Month of January

January 31, 2014

Letters to the Editor: Burzynski: Reviewers Sought To Discredit Antineoplaston Therapy

October 30, 1998

Newest NIH Institute, NIBIB, Gets An Acting Director.

May 11, 2001

ODAC Nixes Abraxane for Adjuvant Breast Cancer, While Genasense Falls Victim to Its Randomized Trial.

September 8, 2006

NCI selects nanotech centers for funding.

October 14, 2005